Do direct oral anticoagulants reduce the incidence of oral anticoagulation-related intracerebral hemorrhage compared to vitamin K antagonists?
Population-wide cohorts of patients receiving oral anticoagulants over two 5-year periods
Direct oral anticoagulants (DOACs)
Vitamin K antagonists (VKAs)
Incidence of oral anticoagulation-related intracerebral hemorrhage (ICH)safety
Population-wide data demonstrates that despite a near-doubling of oral anticoagulant use, intracerebral hemorrhage incidence remained stable, driven by the safety advantage of DOACs over VKAs.
ICH incidence remained stable despite near-doubled OAC use. The lower ICH rates with DOACs compared to VKAs support their safety advantage.
Building similarity graph...
Analyzing shared references across papers
Loading...
Liisa Tomppo
Hanne Sallinen
Otto Lankinen
SHILAP Revista de lepidopterología
Annals of Medicine
King's College London
University of Helsinki
Helsinki University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Tomppo et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d892d16c1944d70ce040be — DOI: https://doi.org/10.1080/07853890.2026.2652115